Install
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
- 94articles · 30d
- 1+ day agolatest article
- Aug 17, 2026earliest in window
- 95%with images
- 86avg words
- health 56
- business 43
- biotech 35
- fda 28
- pharma 28
- biotechnology 26
- cancer 21
- drug development 21
- clinical trials 19
- type-newspost 19
- tmt newswire 16
- globenewswire 15
- pharmaceuticals 15
- stat+ 15
- biopharma 13
- markets 13
- oncology 13
- (midwest communications 12
- artificial intelligence 12
- business & health 11
- Health & Wellness 74
- Medical 63
- Science & Technology 31
- Health 30
- Economy, Business & Finance 27
- Finance & Business 21
- Business & Industrial 15
- Science & Nature 7
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Akeso details survival win for its PD-1xVEGF drug versus Keytruda
1+ day, 9+ hour ago (76+ words) Endpoints News Akeso details survival win for its PD-1xVEGF drug versus Keytruda Akeso and Summit Therapeutics claimed a key win over Keytruda at the start of September,…...
Shionogi's stroke drug fails mid-stage; Bayer's Hyrnuo gets expanded label in NSCLC
3+ day, 20+ hour ago (52+ words) Endpoints News Shionogi's stroke drug fails mid-stage; Bayer's Hyrnuo gets expanded label in NSCLC Plus news about Tevard Biosciences, Disc Medicine, InduPro, EMD Serono and Frazier Life Sciences....
FDA places partial hold on Biohaven's ion channel drug
3+ day, 21+ hour ago (77+ words) FDA places partial hold on Biohaven’s ion channel drug Endpoints News FDA places partial hold on Biohaven's ion channel drug The FDA has placed a troubled Biohaven program on partial clinical…...
ARPA-H selects companies to build AI tools for heart disease
4+ day, 17+ hour ago (76+ words) Endpoints News ARPA-H selects companies to build AI tools for heart disease UpDoc, Tempus AI and Atman Health will participate in a new program that aims to build FDA-au…...
Beeline Medicines reports promising Phase 2 lupus data
5+ day, 12+ min ago (81+ words) Beeline Medicines reports promising mid-stage lupus data Endpoints News Beeline Medicines reports promising mid-stage lupus data The business of advancing shelved pharma assets continues to reap…...
Tyra finds ray of sunshine in otherwise cloudy Phase 2 bladder cancer data
5+ day, 12+ min ago (81+ words) Endpoints News Tyra finds ray of sunshine in otherwise cloudy Phase 2 bladder cancer data Tyra Biosciences wants to challenge Johnson & Johnson in a low-risk form of bladder cancer....
Why apps want your medical records
5+ day, 17+ hour ago (58+ words) Endpoints News Why apps want your medical records In the past six months or so, just about every tech giant and tons of digital health startups with apps have been telling users that … Think we're…...
Moonwalk raises $70M to test siRNA treatment for obesity
5+ day, 23+ hour ago (75+ words) Endpoints News Moonwalk raises $70M to test siRNA treatment for obesity Moonwalk Biosciences is heading to the clinic with an obesity program and has raised $70 million for…...
Why consumer apps set their sights on patient health records
5+ day, 22+ hour ago (70+ words) Endpoints News Why consumer apps set their sights on patient health records Just a few years ago, if you wanted your full medical records, you’d have to remember all the places you’ve received…...
Inhibrx opens door to cancer vaccine combo for its OX40 agonist
5+ day, 23+ hour ago (154+ words) Endpoints News We value your privacy We use third-party cookies that help us analyze how you use this website and store your preferences. However, you can opt out of these cookies by checking "Do Not Sell or Store My Personal…...